Generic placeholder image

Current Cardiology Reviews


ISSN (Print): 1573-403X
ISSN (Online): 1875-6557

Research Article

Adherence to Congestive Heart Failure Guidelines and Outcome in the Middle East

Author(s): Raed Aqel*, Tareq Alzughayyar, Jihad Zalloum, Qais Salah, Qutaiba Qafisheh and Mahmoud Izraiq

Volume 20, Issue 3, 2024

Published on: 23 November, 2023

Article ID: e231123223747 Pages: 5

DOI: 10.2174/011573403X256576231017110252

open access plus


Background: Adherence to Congestive Heart Failure with reduced Ejection Fraction (CHFrEF) guidelines is not easily attainable everywhere, particularly in countries with a high prevalence of low socioeconomic status, which includes many Middle Eastern countries. However, it is well-established that adherence to the guidelines is associated with lower mortality and morbidity rates.

Objective: Our objective is to investigate the adherence to the degree of treatment guideline in CHFrEF within a patient population in the Middle East and correlate the level of compliance both fully and partially with morbidity and mortality outcomes.

Methods and Statistics: We conducted a retrospective study on patients with CHFrEF in the Middle East region who were maintained on Sacubitril/Valsartan for up to 4 years (190 patients). This study included follow-up assessments for morbidity and mortality rates and their correlation with the level of adherence to guidelines.

Results: Statistical analysis was performed using IBM SPSS® 27th version. In both the partial adherence group and the full adherence group, there was a statistically significant improvement in NYHA (pretreatment and post-treatment) and Ejection fraction (pretreatment and posttreatment). This means that regardless of the level of adherence to the use of Sacubitril/Valsartan in CHFrEF, there was an overall improvement in the morbidity and mortality rates over the four years of follow-up.

Conclusion: While we fully support the idea of achieving full CHFrEF guideline adherence, we recognize the difficulty of this task. Nevertheless, this study reinforces the notion that any degree of adherence to guideline is correlated with better morbidity and mortality rates over a long-term follow-up.

Keywords: Congestive, heart failure, guidelines, Middle East, socioeconomical, ejection fraction, morbidity and mortality rates.

Graphical Abstract
Nguyen T, Le KK, Cao HTK, et al. Association between in-hospital guideline adherence and postdischarge major adverse outcomes of patients with acute coronary syndrome in Vietnam: A prospective cohort study. BMJ Open 2017; 7(10): e017008.
[] [PMID: 28982823]
DiMatteo MR. Variations in patients’ adherence to medical recommendations: A quantitative review of 50 years of research. Med Care 2004; 42(3): 200-9.
[] [PMID: 15076819]
Aqel R, Saleh M, Jubeh W. LCZ696 effect on improving quality of life and ejection fraction of Palestinian patients with heart failure and reduced ejection fraction. J R Med Serv 2019; 26(2): 73-8.
Aqel R, Alzughayyar TZ, Abukhalaf SA, Misk RA, Zalloum JS. Long-term mortality and morbidity related to congestive heart failure with reduced ejection fraction (CHFrEF) in Palestinian patients maintained on submaximal sacubitril/valsartan doses: A pilot study. J Renin Angiotensin Aldosterone Syst 2021; 2021: 1-6.
[] [PMID: 35027945]
Llorca C, Cortés Castell E, Ribera Casado JM, et al. Factors associated with non-adherence to drugs in patients with chronic diseases who go to pharmacies in Spain. Int J Environ 2021; 18(8): 4308.
Komajda M, Schöpe J, Wagenpfeil S, et al. Physicians’ guideline adherence is associated with long‐term heart failure mortality in outpatients with heart failure with reduced ejection fraction: The QUALIFY international registry. Eur J Heart Fail 2019; 21(7): 921-9.
[] [PMID: 30933403]
Murphy SP, Prescott MF, Camacho A, et al. Atrial natriuretic peptide and treatment with sacubitril/valsartan in heart failure with reduced ejection fraction. JACC Heart Fail 2021; 9(2): 127-36.
[] [PMID: 33189632]
McMurray JJV, Packer M, Desai AS, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014; 371(11): 993-1004.
[] [PMID: 25176015]
Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: A report of the american college of cardiology/american heart association joint committee on clinical practice guidelines. Circulation 2022; 145(18): e895-e1032.
[] [PMID: 35363499]
Dai L, Dorje T, Gootjes J, et al. Primary care adherence to heart failure guidelines in diagnosis, evaluation and routine management (PATHFINDER): A randomised controlled trial protocol. BMJ Open 2023; 13(3)
Komajda M, Lapuerta P, Hermans N, et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J 2005; 26(16): 1653-9.
[] [PMID: 15827061]
Chauke GD, Nakwafila O, Chibi B, Sartorius B, Mashamba-Thompson T. Factors influencing poor medication adherence amongst patients with chronic disease in low-and-middle-income countries: A systematic scoping review. Heliyon 2022; 8(6): e09716.
[] [PMID: 35770147]
Ahn MS, Yoo BS, Son JW, et al. Evaluation of adherence to guideline for heart failure with reduced ejection fraction in heart failure with preserved ejection fraction and with or without atrial fibrillation. J Korean Med Sci 2021; 36(40): e252.
[] [PMID: 34664798]
Komajda M, Cowie MR, Tavazzi L, Ponikowski P, Anker SD, Filippatos GS. Physicians’ guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: The QUALIFY international registry. Eur J Heart Fail 2017; 19(11): 1414-23.
[] [PMID: 28463464]
Rasmussen AA, Wiggers H, Jensen M, et al. Patient-reported outcomes and medication adherence in patients with heart failure. Eur Heart J Cardiovasc Pharmacother 2021; 7(4): 287-95.
[] [PMID: 32761093]
Parikh NS, Parker RM, Nurss JR, Baker DW, Williams MV. Shame and health literacy: The unspoken connection. Patient Educ Couns 1996; 27(1): 33-9.
[] [PMID: 8788747]
Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc 2011; 86(4): 304-14.
[] [PMID: 21389250]
Chen Y, Schaefer JJ, Iyer SR, et al. Long-term blood pressure lowering and cGMP-activating actions of the novel ANP analog MANP. Am J Physiol Regul Integr Comp Physiol 2020; 318(4): R669-76.
[] [PMID: 32022596]

© 2024 Bentham Science Publishers | Privacy Policy